AnaptysBio, Inc. (ANAB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 25.56M | 108.25M | 76.32M | 22.26M | 27.77M | 43.11M | 30.02M | 10.97M | 7.18M | 9.01M | 3.32M | 3.46M |
| Revenue Growth % | -7.98% | 151.08% | 154.26% | 102.93% | 286.84% | 378.77% | 804.67% | 217.08% | 422.49% | 32.27% | 156.61% | 184.54% |
| Cost of Goods Sold | 610K | -107.99M | 31.41M | 37.82M | 41.18M | 42.59M | 42.21M | 42M | 37.04M | 33.52M | 30.88M | 32.92M |
| COGS % of Revenue | 2.39% | -99.76% | 41.15% | 169.9% | 148.28% | 98.78% | 140.63% | 382.8% | 515.98% | 372.29% | 930.62% | 951.53% |
| Gross Profit | 24.95M | 216.24M | 44.91M | -15.56M | -13.41M | 524K | -12.2M | -31.03M | -29.86M | -24.52M | -27.56M | -29.46M |
| Gross Margin % | 97.61% | 199.76% | 58.85% | -69.9% | -48.28% | 1.22% | -40.63% | -282.8% | -415.98% | -272.29% | -830.62% | -851.53% |
| Gross Profit Growth % | 286.04% | 41166.6% | 468.29% | 49.85% | 55.1% | 102.14% | 55.75% | -5.3% | 11.08% | -48.01% | -32.68% | -50.11% |
| Operating Expenses | 59.58M | 149.34M | 10.21M | 10.61M | 14.13M | 10.19M | 10.56M | 9.29M | 12.34M | 17.61M | 10.17M | 10.68M |
| OpEx % of Revenue | 233.15% | 137.96% | 13.38% | 47.65% | 50.88% | 23.64% | 35.19% | 84.72% | 171.86% | 195.61% | 306.57% | 308.67% |
| Selling, General & Admin | 26.2M | 15.79M | 10.21M | 10.61M | 14.13M | 10.19M | 10.56M | 9.29M | 12.34M | 10.28M | 10.17M | 10.68M |
| SG&A % of Revenue | 102.53% | 14.59% | 13.38% | 47.65% | 50.88% | 23.64% | 35.19% | 84.72% | 171.86% | 114.11% | 306.57% | 308.67% |
| Research & Development | 33.86M | 25.56M | 31.41M | 37.82M | 41.18M | 42.59M | 42.21M | 42M | 37.04M | 40.86M | 30.88M | 32.92M |
| R&D % of Revenue | 132.5% | 23.61% | 41.15% | 169.9% | 148.28% | 98.78% | 140.63% | 382.8% | 515.98% | 453.79% | 930.62% | 951.53% |
| Other Operating Expenses | -480K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -34.64M | 66.9M | 34.7M | -26.17M | -27.54M | -9.67M | -22.76M | -40.32M | -42.2M | -42.13M | -37.73M | -40.14M |
| Operating Margin % | -135.53% | 61.8% | 45.47% | -117.55% | -99.16% | -22.43% | -75.81% | -367.52% | -587.84% | -467.91% | -1137.19% | -1160.2% |
| Operating Income Growth % | -25.77% | 791.84% | 252.5% | 35.1% | 34.74% | 77.05% | 39.69% | -0.44% | 4.95% | -62.23% | -27.33% | -44.4% |
| EBITDA | -34.03M | 67.51M | 35.31M | -25.57M | -26.93M | -9.07M | -22.16M | -39.73M | -41.6M | -41.97M | -37.14M | -39.56M |
| EBITDA Margin % | -133.15% | 62.36% | 46.27% | -114.85% | -96.98% | -21.04% | -73.83% | -362.1% | -579.41% | -466.07% | -1119.35% | -1143.24% |
| EBITDA Growth % | -26.34% | 844.37% | 259.35% | 35.64% | 35.25% | 78.39% | 40.33% | -0.43% | 5.05% | -65.45% | -27.86% | -45.28% |
| D&A (Non-Cash Add-back) | 610K | 606K | 610K | 601K | 606K | 601K | 596K | 595K | 605K | 165K | 592K | 587K |
| EBIT | -34.64M | 66.9M | 37.63M | -18.98M | -21.22M | -4.41M | -17.44M | -35.7M | -37.62M | -34.8M | -32.88M | -35.49M |
| Net Interest Income | -18.21M | -17.2M | -19.59M | -15.95M | -13.65M | -12.14M | -10.09M | -6.33M | -1.73M | -78K | 423K | 295K |
| Interest Income | 2.65M | 2.51M | 2.92M | 3.65M | 4.41M | 5.26M | 5.32M | 4.62M | 4.58M | 4.88M | 4.85M | 4.65M |
| Interest Expense | 20.86M | 19.71M | 22.52M | 19.61M | 18.06M | 17.4M | 15.41M | 10.95M | 6.32M | 4.96M | 4.43M | 4.36M |
| Other Income/Expense | -18.21M | -17.21M | -19.59M | -12.42M | -11.75M | -12.12M | -10.09M | -6.33M | -1.74M | -80K | 424K | 298K |
| Pretax Income | -52.84M | 49.7M | 15.11M | -38.59M | -39.28M | -21.79M | -32.85M | -46.65M | -43.94M | -42.22M | -37.31M | -39.84M |
| Pretax Margin % | -206.78% | 45.91% | 19.8% | -173.34% | -141.46% | -50.54% | -109.44% | -425.22% | -612.01% | -468.8% | -1124.41% | -1151.59% |
| Income Tax | 40K | 81K | 0 | 39K | 44K | -6K | 0 | 9K | 0 | -4K | 0 | 0 |
| Effective Tax Rate % | -0.08% | 0.16% | 0% | -0.1% | -0.11% | 0.03% | 0% | -0.02% | 0% | 0.01% | 0% | 0% |
| Net Income | -52.88M | 49.61M | 15.11M | -38.63M | -39.33M | -21.78M | -32.85M | -46.66M | -43.94M | -42.21M | -37.31M | -39.84M |
| Net Margin % | -206.93% | 45.83% | 19.8% | -173.52% | -141.62% | -50.53% | -109.44% | -425.3% | -612.01% | -468.75% | -1124.41% | -1151.59% |
| Net Income Growth % | -34.47% | 327.75% | 146% | 17.21% | 10.49% | 48.39% | 11.95% | -17.1% | 0.72% | -59.81% | -11.36% | -22.4% |
| Net Income (Continuing) | -52.88M | 49.61M | 15.11M | -38.63M | -39.33M | -21.78M | -32.85M | -46.66M | -43.94M | -42.21M | -37.31M | -39.84M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.84 | 1.58 | 0.52 | -1.34 | -1.28 | -0.77 | -1.14 | -1.71 | -1.64 | -1.57 | -1.41 | -1.50 |
| EPS Growth % | -43.75% | 305.19% | 145.61% | 21.64% | 21.95% | 50.96% | 19.15% | -14% | 5.2% | -68.82% | -6.82% | -13.64% |
| EPS (Basic) | -1.84 | 1.79 | 0.54 | -1.34 | -1.28 | -0.77 | -1.14 | -1.71 | -1.64 | -1.57 | -1.41 | -1.50 |
| Diluted Shares Outstanding | 28.69M | 31.34M | 29.02M | 28.81M | 30.64M | 30.45M | 28.89M | 27.36M | 26.8M | 26.59M | 26.55M | 26.63M |
| Basic Shares Outstanding | 28.69M | 27.79M | 29.06M | 28.81M | 30.64M | 30.45M | 28.82M | 27.36M | 26.8M | 26.59M | 26.55M | 26.63M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |